ZANOTTI, Ilaria
 Distribuzione geografica
Continente #
NA - Nord America 5.249
AS - Asia 4.625
EU - Europa 4.549
SA - Sud America 762
AF - Africa 213
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 1
Totale 15.408
Nazione #
US - Stati Uniti d'America 5.116
SG - Singapore 1.895
CN - Cina 1.564
IT - Italia 1.163
IE - Irlanda 697
BR - Brasile 617
SE - Svezia 606
FI - Finlandia 560
DE - Germania 460
UA - Ucraina 403
HK - Hong Kong 358
VN - Vietnam 296
NL - Olanda 181
ZA - Sudafrica 172
TR - Turchia 169
GB - Regno Unito 133
RU - Federazione Russa 96
CA - Canada 91
FR - Francia 83
IN - India 73
AR - Argentina 65
KR - Corea 59
AT - Austria 38
ID - Indonesia 37
BD - Bangladesh 33
JP - Giappone 30
BE - Belgio 29
IQ - Iraq 29
MX - Messico 28
EC - Ecuador 21
PL - Polonia 19
CZ - Repubblica Ceca 17
ES - Italia 17
CO - Colombia 16
CI - Costa d'Avorio 13
IR - Iran 11
PK - Pakistan 11
VE - Venezuela 11
CL - Cile 10
PY - Paraguay 10
EU - Europa 9
JO - Giordania 8
UY - Uruguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
LT - Lituania 6
AL - Albania 5
KE - Kenya 5
KZ - Kazakistan 5
MA - Marocco 5
RS - Serbia 5
EG - Egitto 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CM - Camerun 3
HU - Ungheria 3
OM - Oman 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GA - Gabon 2
GR - Grecia 2
JM - Giamaica 2
LB - Libano 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TG - Togo 1
Totale 15.406
Città #
Singapore 934
Dublin 695
Chandler 607
Ashburn 558
Beijing 469
Jacksonville 443
Santa Clara 430
Hong Kong 357
Dallas 304
Parma 280
Ann Arbor 238
Dearborn 210
Boardman 200
Johannesburg 161
Nanjing 160
New York 160
Princeton 140
Izmir 139
Hefei 127
Ho Chi Minh City 112
Wilmington 96
Milan 93
Bremen 87
San Mateo 85
Shanghai 83
Los Angeles 74
Chicago 73
Munich 72
Toronto 65
Hanoi 63
Shenyang 63
São Paulo 62
Bologna 59
Seoul 58
Moscow 57
Helsinki 50
Nanchang 46
Kunming 42
Jinan 40
Buffalo 39
Des Moines 39
Hebei 39
Columbus 38
Modena 38
Woodbridge 35
Grafing 33
Tianjin 33
Seattle 32
Vienna 32
Council Bluffs 30
Brussels 28
Houston 28
Jiaxing 28
Rome 27
Marseille 25
Changsha 24
Guangzhou 24
Jakarta 23
Turku 21
Belo Horizonte 20
Hangzhou 19
The Dalles 18
Zhengzhou 18
Brooklyn 17
Haiphong 16
Bergamo 15
Norwalk 15
Nuremberg 15
Reggio Emilia 15
Rio de Janeiro 15
Turin 15
Curitiba 14
London 14
Phoenix 14
San Jose 14
Taiyuan 14
Tokyo 14
Abidjan 13
Brasília 13
Brno 13
Warsaw 13
Acquafredda 12
Istanbul 12
San Francisco 12
Brescia 11
Fremont 11
Kinuta 11
Montreal 11
Bari 10
Bengaluru 10
Düsseldorf 10
Guayaquil 10
Orem 10
Stockholm 10
Baghdad 9
Catania 9
Chennai 9
Formigine 9
Manchester 9
Poplar 9
Totale 9.136
Nome #
Principi di farmacognosia e fitoterapia. Seconda edizione 590
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 228
The adaptation of lipid profile of human fibroblasts to alginate 2D films and 3D printed scaffolds 209
Three-Dimensional (3D) Printed Silver Nanoparticles/Alginate/Nanocrystalline Cellulose Hydrogels: Study of the Antimicrobial and Cytotoxicity Efficacy 201
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 187
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 185
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 180
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction 168
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 150
Atheroprotective effects of (poly)phenols: focus on cell cholesterol metabolism 150
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 148
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial 146
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 145
Antiatherogenic effects of ellagic acid and urolithins in vitro 144
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 138
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 136
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 133
Role of Apolipoprotein E in cellular cholesterol efflux 132
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 130
Ruolo dell’apolipoproteine E nell’efflusso cellulare di colesterolo 128
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 128
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 128
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 126
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G>C mutation in ABCA1 gene 126
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 126
HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies 125
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 124
Recettori LXR e trasporto inverso del colesterolo 124
Cellular cholesterol efflux pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations 123
Cholesterol efflux and reverse cholesterol transport 122
Polyphenol health effects on cardiovascular and neurodegenerative disorders: A review and meta-analysis 122
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 121
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux 120
Analysis of lipid efflux in fibroblasts from Niemann Pick Type C disease subjects 120
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction 119
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 119
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 119
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 119
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 118
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 118
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 118
Approccio nutraceutico al rischio cardiovascolare residuo 117
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 117
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 115
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 114
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 114
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 114
Dysfunctional high-density lipoproteins in type 2 diabetes mellitus: Molecular mechanisms and therapeutic implications 114
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 113
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 113
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 113
Probucol inhibits ABCA1-mediated cellular lipids efflux 112
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 112
Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells 111
Apparato cardiovascolare 107
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 107
Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis 107
Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays. 106
Pitavastatin Differently Modulates ATP Binding Cassette A1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 105
ATTIVITA’ IPOLIPIDEMIZZANTE DEL NUTRACEUTICO OLEACTIV® NEL MODELLO DEL CRICETO GOLDEN SYRIAN 105
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept 104
Fu5AH express functional ABCA1 upon treatment with 22OH-cholesterol and cis-9 retinoic acid 104
Impaired ATP-binding cassette Transporter AI-mediated Sterols Efflux from Oxidized LDL Loaded Macrophages 103
Phenyl-γ-valerolactones, flavan-3-ol colonic metabolites, protect brown adipocytes from oxidative stress without affecting their differentiation or function 103
The LXR agonist T0901317 promotes the reverse cholesterol transport frommacrophages by increasing plasma efflux potential 101
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 100
Anti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv®, in a Hypercholesterolemia-Induced Golden Syrian Hamster Model 100
ROLE OF APOLIPOPROTEIN E IN CELLULAR CHOLESTEROL EFFLUX 99
Modulazione dell'omeostasi del colesterolo da parte di proprotein convertase subtilisin/kexin type 9 (PCSK9) nel macrofago 99
Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability and telomere length in healthy octogenarians 99
IN VIVO TREATMENT WITH CYCLOSPORINE A INCREASES EFFLUX POTENTIAL OF MOUSE PLASMA VIA ATP-BINDING CASSETTE TRANSPORTER ABCA1 98
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo 98
Pitavastatin Differently Modulates ABCA1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 98
THE THIENOTRIAZOLODIAZEPINE RO 11-1464 INCREASES PLASMA APOA-I AND PROMOTES REVERSE CHOLESTEROL TRANSPORT AND FECAL STEROL EXCRETION IN HUMAN APOA-I TRANSGENIC MICE 98
Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation. 98
Increased ABCA1-mediated cholesterol efflux potential of sera from ApoAI milano carriers 97
Probucol Inhibition of ATP-Binding Cassette A1-Mediated Cellular Lipid Efflux 97
ROLE OF APOLIPOPROTEIN E IN THE REVERSE CHOLESTEROL TRANSPORT IN VIVO 97
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 97
La Lercanidipina riduce la tossicita' cellulare indotta dall'accumulo di colesterolo libero 96
TRASPORTO INVERSO DEL COLESTEROLO: FATTORI DETERMINANTI L’EFFICIENZA DEL PROCESSO 96
Effect of apoA-I overexpression on “in vivo” reverse cholesterol transport from macrophages 96
Cholesterol efflux from oxidized LDL loaded macrophages 95
Effect of HDL composition and size on cellular cholesterol efflux 95
Microbiota intestinale: un nuovo protagonista nella eziologia e nel trattamento dell'aterosclerosi? 95
Fu5AH cells express functional ABCA1 upon treatment with 22OH-cholesterol and cis-9 retinoic acid 94
A BENZODIAZEPINE ANALOGUE PROMOTES FAECAL STEROL EXCRETION IN APOA-I OVEREXPRESSING MICE 94
Impact of dietary lipids on the reverse cholesterol transport: What we learned from animal studies 94
Modulation of cholesterol efflux in human THP-I macrophages 93
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 93
Investigation on mechanisms of cholesterol efflux in human monocytes/macrophages THP-1 93
Ruolo dell'apolipoproteina E nel trasporto inverso del colesterolo 93
Impact of apolipoprotein E (apoE) deficiency on reverse cholesterol transport in vivo 92
Impaired ATP-binding Cassette Transporter AI-mediated sterol efflux from oxidized LDL loaded macrophages 92
Therapeutic perspectives of Eph–ephrin system modulation 92
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 91
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITS ATP BINDING CASSETTE TRANSPORTER A1-MEDIATED CHOLESTEROL EFFLUX FROM MACROPHAGES 90
Impact of Bifidobacterium bifidum PRL2010 on lipid metabolism in vitro and in vivo 90
Effect of LXR agonists on reverse cholesterol transport in vivo 90
Probucol inhibition of ABCA1-mediated cellular lipid efflux 89
Totale 12.152
Categoria #
all - tutte 54.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021660 0 0 0 0 0 103 118 35 197 42 133 32
2021/2022707 24 17 13 41 24 64 67 92 39 55 39 232
2022/20232.534 293 242 158 175 244 273 36 127 862 32 72 20
2023/20241.094 45 88 17 43 63 285 76 80 54 78 71 194
2024/20253.411 93 171 254 246 360 347 100 153 476 318 277 616
2025/20263.918 648 695 790 573 979 233 0 0 0 0 0 0
Totale 15.667